Allergan Says New Suitor Approached It About A Deal
Allergan Inc., the drugmaker battling a hostile $55 billion takeover by Valeant Pharmaceuticals International Inc., confirmed in a Monday securities filing that another party had approached it about a potential transaction....To view the full article, register now.
Already a subscriber? Click here to view full article